C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/14 (2006.01) A61K 31/445 (2006.01) C07D 211/22 (2006.01) C07D 295/108 (2006.01)
Patent
CA 2326804
Compounds and methods are provided for the alleviation or treatment of diseases or conditions in which modification of muscarinic m1 receptor activity has a beneficial effect. In the method, a therapeutically effective amount of a selective muscarinic m1 agonist compound is administered to a patient in need of such treatment.
La présente invention concerne des composés et des procédés permettant de soulager ou de traiter des affections ou des états dans le cas desquels une modification de l'activité du récepteur muscarinique m1 présente un effet bénéfique. Le procédé consiste à administrer à un patient justifiant un tel traitement une quantité suffisante d'un composé agoniste muscarinique m1 sélectif.
Brann Mark Robert
Currier Erika Anne
Duggento Katharan Lauri
Friberg Mikael
Messier Terri
Acadia Pharmaceuticals Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Compounds with activity on muscarinic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds with activity on muscarinic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds with activity on muscarinic receptors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1425412